100% found this document useful (1 vote)
1K views2 pages

Phenobarbital

Phenobarbital is an anticonvulsant and sedative that works by depressing the central nervous system. It is used to treat seizures and as a preoperative sedative. Potential adverse effects include sedation, respiratory depression, hypotension, constipation, rash, and dependence with chronic use. Nurses must carefully monitor dosage and observe patients for adverse effects after administration.

Uploaded by

Arnzz Agbulos
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOC, PDF, TXT or read online on Scribd
100% found this document useful (1 vote)
1K views2 pages

Phenobarbital

Phenobarbital is an anticonvulsant and sedative that works by depressing the central nervous system. It is used to treat seizures and as a preoperative sedative. Potential adverse effects include sedation, respiratory depression, hypotension, constipation, rash, and dependence with chronic use. Nurses must carefully monitor dosage and observe patients for adverse effects after administration.

Uploaded by

Arnzz Agbulos
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOC, PDF, TXT or read online on Scribd
You are on page 1/ 2

Drug Data Generic Name phenobarbital Trade Name Ancalixir, Luminal, Solfoton Patients Dose

Classificatio n Therapeutic" Anticon$ul#an t#, Sedati$e# Pharmacolo gic %arbiturate# Pregnanc& Categor& D

Mechanism of Action &roduce# all le$el# of '(S depre##ion! )epre##e# the #en#ory cortex, decrea#e# motor acti$ity, and alter# cerebellar function! *nhibit# tran#mi##ion in the ner$ou# #y#tem and rai#e# the #ei+ure thre#hold! 'apable of inducing ,#peeding up- en+yme# in the li$er that metaboli+e drug#, bilirubin, and other compound#! Pharmaco)in etics A" Ab#orption i# #lo. but relati$ely complete ,/00 102-! D" 3n4no.n M*'" /52 metaboli+ed by the li$er, 252 excreted unchanged by the 4idney#! Onset &56 30" 0 min! *7,Subcu610"30min *865min Pea) &5,*7,Subcu6 un4no.n *86 30min! Duration &569 hr *7,Subcu, *86 :" hr Drug +alf ,ife (eonate#6 1!808!3 day#; *nfant#6 0!80

Indication General Indications Anticon$ul#ant in tonic"clonic ,grand mal-, partial, and febrile #ei+ure# in children! &reoperati$e #edati$e and in other #ituation# in .hich #edation may be re<uired! =ypnotic ,#hort"term-! Patients Actual Indication

Contraindications =yper#en#iti$ity; 'omato#e patient# or tho#e .ith pre" exi#ting '(S depre##ion; Se$ere re#piratory di#ea#e .ith dy#pnea or ob#truction; 3ncontrolled #e$ere pain; >no.n alcohol intolerance ,elixir only-; Lactation6 )i#continue drug or bottle feed! Precaution =epatic dy#function; Se$ere renal impairment; =i#tory of #uicide attempt or drug abu#e; =ypnotic u#e #hould be #hort"term! 'hronic u#e may lead to dependence; 5%6 'hronic u#e during pregnancy re#ult# in drug dependency in the infant; may re#ult in coagulation defect# and fetal malformation; acute u#e at term may re#ult in re#piratory depre##ion in the ne.born; ?eri6 *initial do#e reduction recommended; =ypnotic u#e #hould be #hort" term! 'hronic u#e may lead to dependence!

Adverse Reaction CN#" hango$er, delirium, depre##ion, dro.#ine##, excitation, lethargy, $ertigo! Resp" re#piratory depre##ion; IV, LA@A(?5S&AS7, broncho#pa#m! C!" IVB hypoten#ion! GI" con#tipation, diarrhea, nau#ea, $omiting! Derm" photo#en#iti$ity, ra#he#, urticaria! ,ocal" phlebiti# at *8 #ite! M#" arthralgia, myalgia, neuralgia! Misc" hyper#en#iti$ity reaction# including A(?*5C)C7A and SC@37 S*'>(CSS, phy#ical dependence, p#ychological dependence!

Nursing Responsibilities -efore 1! A##e# patientD# diagno#i#! 2! A##e## patientD# mental #tatu#! 3! Ea4e 8/S of patient! :! A##e## patientD# L5'! 5! 5btain pre#cribed do#e! During 1! 'onfirm patientD# identity! 2! Admini#ter medication at the right pre#cribed route! 3! )o not go o$er the recommended do#e! :! Super$i#e ambulation and tran#fer of patient# follo.ing admini#tration! 5! Eablet# may be cru#hed and mixed .ith food# or fluid# for patient# .ith difficulty #.allo.ing! After 1! 5b#er$e proper documentation of admini#tered medication! 2! Cn#ure that patient ha# fully #.allo.ed oral form of medication! 3! 5b#er$e patientD# beha$ior clo#ely for atlea#t 15"30

Minimum Dose PO I!" 1mg/day #ubcu$IM" 3mg/day Ma%imum Dose PO$I!$IM$ #ubcu" 320mg/day Contents phenobarbital Availabilit& and color Tablets" 8 mg, 15 mg, 30 mg, 0 mg, 100 mg! Capsules" 15 mg! 'li%ir" 20 mg/5 mL! In(ection" 30 mg/mL in 1" mL prefilled #yringe#, 0 mg/mL in 1" mL prefilled

#yringe#, 5 mg/mL in 1" mL $ial#, 130 mg/mL in 1" mL prefilled #yringe#, 1"mL $ial#, and 1" mL ampule#! Routes of administra tion *8,&5,Subcu,*7

5!5 day#; 'hildren6 1!503 day#; Adult#6 20 day#!

!Drug interaction .drug to drug Additi$e '(S depre##ion .ith other CN# depressants, including alcohol, antihistamines, opioid analgesics, and other sedative/ h&pnotics! 7ay induce hepatic en+yme# that metaboli+e other drug#,ptheir effecti$ene##, including hormonal contraceptives, 0arfarin, chloramphenicol, c&closporine, dacarba1ine, corticosteroids, tric&clic antidepressants, felodipine, clona1epam, carbama1epine, verapamil, theoph&lline, metronida1ole, and 2uinidine!

minute# after admini#tration! :! 7onitor patientD# 8/S throughout the therapy! 5! *n#truct patient to re#t to decrea#e ri#4 of fall#!

#ource" )eglin, F! et! Al! 2001! )a$i#D# )rug ?uide for (ur#e#! 12 th ed! G!A! )a$i#! pp 1015"101/

You might also like